Back to top
more

Nutex Health (NUTX)

(Delayed Data from NSDQ)

$0.75 USD

0.75
251,611

+0.01 (0.76%)

Updated May 24, 2024 04:00 PM ET

After-Market: $0.71 -0.04 (-4.77%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 249)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NUTX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Nutex Health Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 22 34 15 0 1
Receivables 63 58 2 0 0
Notes Receivable 0 0 0 0 0
Inventories 3 4 0 0 0
Other Current Assets 3 2 0 0 0
Total Current Assets 91 98 18 0 1
Net Property & Equipment 81 82 0 0 0
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 38 38 68 0 5
Deposits & Other Assets 0 0 0 0 0
Total Assets 398 432 86 0 7
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 1 0 2
Accounts Payable 25 28 4 1 2
Current Portion Long-Term Debt 14 15 4 0 0
Current Portion Capital Leases 4 4 0 0 0
Accrued Expenses 13 6 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 58 55 9 1 5
Mortgages 0 0 0 0 0
Deferred Taxes/Income 5 10 2 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 26 23 0 0 0
Non-Current Capital Leases 214 204 0 0 0
Other Non-Current Liabilities 0 0 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 319 311 11 1 5
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 0 0 0
Capital Surplus 470 459 107 17 14
Retained Earnings -409 -363 -32 -18 -13
Other Equity 18 24 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 79 120 75 -1 2
Total Liabilities & Shareholder's Equity 398 432 86 0 7
Total Common Equity 79 120 75 -1 2
Shares Outstanding 44.70 43.30 3.10 0.30 0.30
Book Value Per Share 1.77 2.78 24.24 -3.77 6.20

Fiscal Year End for Nutex Health Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents 30 22 27 33 33
Receivables 66 63 55 52 52
Notes Receivable 0 0 0 0 0
Inventories 3 3 3 2 3
Other Current Assets 2 3 6 5 1
Total Current Assets 100 91 90 92 89
Net Property & Equipment 81 81 86 83 77
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 37 38 40 37 38
Deposits & Other Assets 1 0 0 0 0
Total Assets 404 398 480 436 430
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 24 25 24 32 19
Current Portion Long-Term Debt 12 14 23 19 13
Current Portion Capital Leases 4 4 4 4 4
Accrued Expenses 18 13 15 0 10
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 60 58 67 57 48
Mortgages 0 0 0 0 0
Deferred Taxes/Income 5 5 8 9 10
Convertible Debt 0 0 0 0 0
Long-Term Debt 26 26 19 25 25
Non-Current Capital Leases 213 214 264 220 221
Other Non-Current Liabilities 5 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 324 319 375 328 321
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 1 1 1 1
Capital Surplus 472 470 467 464 460
Retained Earnings -409 -409 -377 -372 -368
Other Equity 17 18 15 16 17
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 80 79 105 108 110
Total Liabilities & Shareholder's Equity 404 398 480 436 430
Total Common Equity 80 79 105 108 110
Shares Outstanding 49.50 44.70 44.10 43.50 43.50
Book Value Per Share 1.62 1.77 2.38 2.49 2.52